This protein is a component of the alpha-ketoglutarate dehydrogenase complex, crucial for energy metabolism within the Krebs cycle. DLST Activators encompass a variety of chemical structures and mechanisms, from polyphenols like resveratrol and curcumin to more synthetic compounds like metformin and troglitazone. While these compounds come from different chemical families, including but not limited to flavonoids, organic acids, and biguanides, they share the common feature of influencing DLST expression. These compounds are often explored in the context of cellular respiration, mitochondrial function, and overall energy metabolism, aiming to decipher the complex regulatory networks that control these fundamental cellular processes. As a crucial component of the alpha-ketoglutarate dehydrogenase complex, DLST plays a vital role in the Krebs cycle, a fundamental cellular process for energy generation. The compounds classified as DLST Activators are diverse in both their chemical structures and mechanisms of action.
They range from naturally occurring polyphenols like resveratrol and curcumin to synthetic agents like metformin and dexamethasone. Despite their diverse origins, these compounds share the potential ability to modulate DLST expression and, by extension, impact cellular energy metabolism. For instance, some DLST Activators like retinoic acid or sulforaphane may act through nuclear receptors or cellular pathways, such as the Nrf2 pathway, that have wide-ranging effects on metabolic gene expression. Others, like caffeine and metformin, may influence DLST indirectly through their actions on general metabolic rates or key metabolic sensors like AMP-activated protein kinase (AMPK). It should be emphasized that while these compounds are grouped under the umbrella term "DLST Activators," their effects are often pleiotropic, influencing multiple pathways and genes beyond DLST. Therefore, understanding the specific mechanisms through which each compound acts is an area of active investigation in biochemistry and cellular biology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Phenformin Hydrochloride | 834-28-6 | sc-219590 | 10 g | $117.00 | 4 | |
Similar to Metformin, Phenformin also activates AMPK, a key metabolic regulator, which could upregulate DLST expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, a master regulator of cell growth and metabolism, which may induce DLST expression as a compensatory mechanism. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
AICAR is an AMPK activator that may elevate DLST expression through AMPK’s role in metabolic regulation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium affects multiple signaling pathways, including GSK-3β, which could influence DLST expression indirectly. | ||||||
Salicylic acid | 69-72-7 | sc-203374 sc-203374A sc-203374B | 100 g 500 g 1 kg | $46.00 $92.00 $117.00 | 3 | |
Salicylate can inhibit NF-κB and activate AMPK, potentially upregulating DLST as part of broader metabolic shifts. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
This drug is a PPARγ agonist like Troglitazone and may induce DLST expression by influencing metabolic pathways. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
Another PPARγ agonist, Pioglitazone may have a similar effect on DLST expression as other PPARγ activators. | ||||||